| Project Detail |
Location:
Poland
Project number:
55003
Business sector:
Manufacturing and Services
Notice type:
Private
Approval date:
21 Feb 2024
Status:
Approved
PSD disclosed:
23 Feb 2024
Long-term financing to Zaklady Farmaceutyczne Polpharma S.A. ("Polpharma") and Windstorm Trading and Investments Limited (together referred to as the "Group", the "Client") as part of a larger syndicate to support an investment program involving business expansion and R&D activities of both generics and biologics divisions of the Group, as well as for general corporate purposes and refinancing.
Project Objectives
The project will strengthen the Groups position in Poland, Central and Eastern Europe and other export markets and increase its global presence through value added products. The investments into the new biological products will allow the Group to establish region-leading competencies in advanced pharmaceutical production and facilitate the global commercialization of its pipeline of biological therapeutics in partnership with the worlds largest pharmaceutical companies, thus entering currently unavailable market segments. |
